Merck opens manufacturing facility in North Carolina
Merck Opens Vaccine Manufacturing Facility in North Carolina
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Drugmakers have been exploring the possibility of government-granted exemptions for domestically manufactured medicines since Trump has threatened to impose 25% tariff on pharmaceutical imports.
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
Achieves ISO9001, EFfCI GMP, and EXCiPACT certifications for its new manufacturing plant.
As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...
12don MSN
Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...
ABUJA, NIGERIA / ACCESS Newswire / March 11, 2025 / In a landmark effort to transform Nigeria's pharmaceutical industry and ...
Irish Examiner on MSN2d
Ireland could lose pharma tax to US after Trump accusations, experts warnUS pharmaceutical companies based in Ireland are more likely to shift profits back to the US than close manufacturing plants ...
With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...
Pharmacists in Nigeria have revealed that low investment and interest in drug and vaccine manufacturing persist because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback